MOTS-c vs Humanin
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Mitochondrial ORF of the 12S rRNA type-c
A mitochondria-derived peptide that regulates metabolic homeostasis. Discovered in 2015, it is being studied for its effects on insulin sensitivity, exercise capacity, and aging.
Also: HN, HNG (S14G-humanin)
A mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity. Being studied for aging and metabolic benefits.
Key Comparison Insights
- MOTS-c is categorized as Hormonal, while Humanin is Anti-Aging.
Detailed Comparison
| Attribute | MOTS-c | Humanin |
|---|---|---|
| Category | Hormonal | Anti-Aging |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | MOTS-c is encoded by mitochondrial DNA and acts as a mitokine, communicating mitochondrial status to the rest of the body. It activates AMPK, improves glucose uptake, enhances fatty acid oxidation, and has systemic metabolic regulatory effects. | Humanin acts through multiple pathways including STAT3 signaling, binding to IGFBP-3, and activating the FPRL1 receptor. It protects neurons from apoptosis, improves insulin sensitivity, and has anti-inflammatory effects. |
| Common Dosing | 5-10 mg weekly 1-3x weekly | 5-10 mg weekly divided into 2-3 injections 2-3x weekly (e.g., Monday, Wednesday, Friday) |
| Administration | Subcutaneous injection | Injection (route varies) |
| Typical Duration | Variable by protocol | Variable |
| Best Time to Take | Morning or pre-workout | Morning |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Studies show MOTS-c improves insulin sensitivity and prevents diet-induced obesity in mice. Research demonstrates enhanced exercise capacity and protection against age-related metabolic decline. Human studies are limited but promising. | Research shows protection against amyloid-beta toxicity in Alzheimer's models. Studies demonstrate improved insulin sensitivity, reduced atherosclerosis in animal models, and potential anti-aging effects. Human studies are limited. |
Frequently Asked Questions: MOTS-c vs Humanin
What is the difference between MOTS-c and Humanin?
MOTS-c is a hormonal peptide that a mitochondria-derived peptide that regulates metabolic homeostasis. discovered in 2015, it is being studied for its effects on insulin sensitivity, exercise capacity, and aging. Humanin is a anti-aging peptide that a mitochondria-derived peptide discovered for its neuroprotective effects against alzheimer's-related toxicity. being studied for aging and metabolic benefits. The main differences lie in their mechanisms of action and clinical applications.
Which is better, MOTS-c or Humanin?
Neither is universally "better" - the choice depends on your specific goals. MOTS-c is typically used for hormonal purposes, while Humanin is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can MOTS-c and Humanin be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using MOTS-c and Humanin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.